Soligenix, Inc.(SNGX)- OTCQB
  • Life Sciences Report | Send Message 15 Jun

    "Preliminary results from $SNGX's Phase 2 study in oral mucositis will be presented"- J. Kolbert. More: http://ow.ly/thmr301iIve
    Reply
      • Life Sciences Report | Send Message 15 Jun

        Soligenix Develops Defenses Against Bioterrorism $SNGX http://seekingalpha.com/p/2wtwz
        Reply
          • Life Sciences Report | Send Message 18 May

            "We are optimistic about $SNGX's lead candidates SGX301 for CTLC and SGX942"- Grant Zeng. More: http://ow.ly/FKwd300luEU
            Reply
              • Life Sciences Report | Send Message 27 Apr

                " $SNGX will be pursuing opportunities for partnership on SGX942 trials"- Grant Zeng. Read more: http://ow.ly/4naQqe
                Reply
                  • Life Sciences Report | Send Message 27 Apr

                    Soligenix Fosters Potent Pipeline Of Orphan Disease Compounds In Areas Of Unmet Medical Need $SNGX http://seekingalpha.com/p/2wj8l
                    Reply
                      • Life Sciences Report | Send Message 20 Apr

                        " $SNGX's current valuation doesn't reflect the potential upside"- Ross Silver. Read more: http://ow.ly/4mV6bC
                        Reply
                          • Life Sciences Report | Send Message 6 Apr

                            " $SNGX's dusquetide shows preclinical efficacy against a broad spectrum of infectious bacteria"- J. Kolbert. More: http://ow.ly/10nlUc
                            Reply
                              • Anthony Alfidi | Send Message 2 Feb

                                Soligenix And Rare Diseases $SNGX http://seekingalpha.com/p/2u7n4
                                Reply
                                  • Anthony Alfidi | Send Message 2 Feb

                                    $SNGX Soligenix survives with non-dilutive funding for disease treatments and biodefense. http://goo.gl/ghj3kE
                                    Reply
                                      • Life Sciences Report | Send Message 20 May 2015

                                        Exceptional Management And Disruptive Products Top The Investment Checklist For Vista... $SNGX, $XON http://seekingalpha.com/p/2e5dm
                                        Reply